Lifeline Biotechnologies Inc (LLBO)

[change-for-a-buck]

"The trials have been approved by the Investigational Review Board (IRB's) of ECH and are currently undergoing the review process at OSU. The trial is expected to be completed within four to 6 months. On completion Cyrcadia will obtain a CE Mark allowing for worldwide sales and marketing outside of the USA. On completion of the trials Cyrcadia will be submitting a 510(k) to the FDA. Post FDA clearance, marketing will begin in the USA. International sales are expected in Q4 of 2015 and US sales in Q1 or Q2 of 2016."
April 2015 PR.